Bitwise MARA Option Income Strategy ETF (NYSEARCA:IMRA) Insider Helen Louise Collins Sells 40,000 Shares

Bitwise MARA Option Income Strategy ETF (NYSEARCA:IMRA) insider Helen Louise Collins sold 40,000 shares of the firm’s stock in a transaction that occurred on Wednesday, March 25th. The stock was sold at an average price of $35.10, for a total value of $1,404,000.00. Following the transaction, the insider owned 25,000 shares in the company, valued at approximately $877,500. The trade was a 61.54% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

Helen Louise Collins also recently made the following trade(s):

• On Tuesday, March 17th, Helen Louise Collins sold 5,000 shares of Bitwise MARA Option Income Strategy ETF stock. The shares were sold at an average price of $27.76, for a total value of $138,800.00.

Bitwise MARA Option Income Strategy ETF Stock Performance

NYSEARCA:IMRA opened at $12.63 on Friday. The firm has a market cap of $3.03 million, a PE ratio of 252.60 and a beta of -6.67. Bitwise MARA Option Income Strategy ETF has a fifty-two week low of $11.99 and a fifty-two week high of $60.73. The business has a 50 day moving average price of $14.41 and a 200-day moving average price of $22.59.

About Bitwise MARA Option Income Strategy ETF

IMARA Inc, a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develops IMR-261, an oral and clinical-ready activator of nuclear factor erythroid 2–related factor 2 for the treatment of hemoglobinopathies, iron disorders, and potentially other areas.